These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38147358)

  • 1. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Sedrakyan A; Altorki NK
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2454-2465.e1. PubMed ID: 30954298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
    Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
    Liou DZ; Chan M; Bhandari P; Lui NS; Backhus LM; Shrager JB; Berry MF
    Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 36063054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapy.
    Schlachtenberger G; Doerr F; Menghesha H; Hagmeyer L; Bennink G; Gaisendrees C; Wahlers T; Hekmat K; Heldwein MB
    Surg Oncol; 2022 Sep; 44():101840. PubMed ID: 36096011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.
    Khullar OV; Liu Y; Gillespie T; Higgins KA; Ramalingam S; Lipscomb J; Fernandez FG
    J Thorac Oncol; 2015 Nov; 10(11):1625-33. PubMed ID: 26352534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
    Kamel MK; Lee B; Harrison SW; Port JL; Altorki NK; Stiles BM
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1907-1915. PubMed ID: 34281703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
    Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Ann Thorac Surg; 2023 Jun; 115(6):1344-1351. PubMed ID: 36126718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
    Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.